Cargando…
Preclinical Animal Models for Dravet Syndrome: Seizure Phenotypes, Comorbidities and Drug Screening
Epilepsy is a common chronic neurological disease affecting almost 3 million people in the United States and 50 million people worldwide. Despite availability of more than two dozen FDA-approved anti-epileptic drugs (AEDs), one-third of patients fail to receive adequate seizure control. Specifically...
Autores principales: | Griffin, Aliesha, Hamling, Kyla R., Hong, SoonGweon, Anvar, Mana, Lee, Luke P., Baraban, Scott C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5994396/ https://www.ncbi.nlm.nih.gov/pubmed/29915537 http://dx.doi.org/10.3389/fphar.2018.00573 |
Ejemplares similares
-
Phenotype-Based Screening of Synthetic Cannabinoids in a Dravet Syndrome Zebrafish Model
por: Griffin, Aliesha, et al.
Publicado: (2020) -
Phenotypic analysis of catastrophic childhood epilepsy genes
por: Griffin, Aliesha, et al.
Publicado: (2021) -
A Novel Long-term, Multi-Channel and Non-invasive Electrophysiology Platform for Zebrafish
por: Hong, SoonGweon, et al.
Publicado: (2016) -
Zebrafish studies identify serotonin receptors mediating antiepileptic activity in Dravet syndrome
por: Griffin, Aliesha L, et al.
Publicado: (2019) -
Perampanel Reduces Hyperthermia-Induced Seizures in Dravet Syndrome Mouse Model
por: Ho, Shih-Yin, et al.
Publicado: (2021)